The Pennsylvania Psychiatric Institute
Welcome,         Profile    Billing    Logout  
 0 Trials 
4 Trials

   

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Kawasaki, Sarah
NCT06548490: GLP-1R Agonist Treatment for Opioid Use Disorder

Not yet recruiting
2
200
US
Semaglutide Pen Injector, Ozempic, Placebo, Dry needle stick
Milton S. Hershey Medical Center, New York University, University of Maryland, National Institute on Drug Abuse (NIDA)
Opioid Use Disorder, Opioid Abuse and Addiction, Narcotic-Related Disorders, Substance-Related Disorders, Chemically-Induced Disorders, Mental Disorder, Opioid
11/26
11/26
NCT04794790: Buprenorphine Induction for Fentanyl Dependent Opioid Users

Withdrawn
1
30
US
Buprenorphine/naloxone
Milton S. Hershey Medical Center
Opioid Dependence Fentanyl
02/24
06/24
NCT04129580: reSET-O RCT (Randomized Controlled Trial)

Active, not recruiting
N/A
100
US
reSET-O app
Milton S. Hershey Medical Center, Columbia University, Pear Therapeutics, Inc., National Institutes of Health (NIH), Research Foundation for Mental Hygiene, Inc.
Opioid-use Disorder
07/23
09/24
Zimmerman, Rachel
NCT04794790: Buprenorphine Induction for Fentanyl Dependent Opioid Users

Withdrawn
1
30
US
Buprenorphine/naloxone
Milton S. Hershey Medical Center
Opioid Dependence Fentanyl
02/24
06/24

Download Options